Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tap

Showing results (61-70 of 235) with videos related to

Pageof 24
Sort By:
Genes, Chromosomes & Cancer|February 16, 2022
FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumorJosephine K Dermawan, Chad M Vanderbilt, Jason C Chang, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2018
Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcomaRobin L Jones, Gary Mo, John R Baldwin, et al.
Journal of Oncology Practice|March 26, 2019
Prognostication and Communication in OncologyThomas W LeBlanc, Jonathan M Marron, Sabha Ganai, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spineMichael R Folkert, Mark H Bilsky, Ashlyn K Tom, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PETMatthias R Benz, Sarah M Dry, Fritz C Eilber, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 10, 2020
Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal TumorMichael J Cavnar, Kenneth Seier, Mithat Gönen, et al.
Urology|June 24, 2018
Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution ExperienceKatie S Murray, Massimiliano Spaliviero, Emily S Tonorezos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2024
Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine LeiomyosarcomaJosephine K Dermawan, Sarah Chiang, Samuel Singer, et al.
Genes, Chromosomes & Cancer|December 4, 2016
BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfallYu-Chien Kao, Yun-Shao Sung, Lei Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2022
The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasmsJosephine K Dermawan, Samuel Singer, William D Tap, et al.
Pageof 24

Showing results (61-70 of 235) with videos related to

Sort By:
Pageof 24
Genes, Chromosomes & Cancer|February 16, 2022
FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumorJosephine K Dermawan, Chad M Vanderbilt, Jason C Chang, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2018
Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcomaRobin L Jones, Gary Mo, John R Baldwin, et al.
Journal of Oncology Practice|March 26, 2019
Prognostication and Communication in OncologyThomas W LeBlanc, Jonathan M Marron, Sabha Ganai, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spineMichael R Folkert, Mark H Bilsky, Ashlyn K Tom, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PETMatthias R Benz, Sarah M Dry, Fritz C Eilber, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 10, 2020
Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal TumorMichael J Cavnar, Kenneth Seier, Mithat Gönen, et al.
Urology|June 24, 2018
Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution ExperienceKatie S Murray, Massimiliano Spaliviero, Emily S Tonorezos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2024
Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine LeiomyosarcomaJosephine K Dermawan, Sarah Chiang, Samuel Singer, et al.
Genes, Chromosomes & Cancer|December 4, 2016
BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfallYu-Chien Kao, Yun-Shao Sung, Lei Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2022
The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasmsJosephine K Dermawan, Samuel Singer, William D Tap, et al.
Pageof 24